Novartis Cites ‘Same Labelling’ Rule In FDA Entresto Petition

‘At Least Entresto 18 ANDAs Have Been Submitted To FDA,’ Novartis Reveals

 
• By Dean Rudge
  
FDA building
The FDA approved the new indication in Feb. 2021 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products